Literature DB >> 15479365

Comprehensive care for haemophilia around the world.

B L Evatt1, C Black, A Batorova, A Street, A Srivastava.   

Abstract

Comprehensive haemophilia care has been defined as the continuing supervision of all medical and psychosocial factors affecting the person with haemophilia family. Services offered by haemophilia treatment centres (HTCs) adopting the comprehensive care model include establishing prophylaxis and other treatment protocols, development of psychosocial, education and research programme, maintenance of a patient registry, genetic and reference diagnostic services and orchestration and management of a wide variety of multidisciplinary interventions. Most centres practising this model of care are based in developed countries and can meet costs for plentiful treatment products through government or insurance-company funding. Not all the programmes are dependent on the level of product supply, however, and many have been supported in countries with emerging economies as part of national healthcare systems, particularly in relation to blood management. In this paper we present perspectives from different areas of the world on how to adopt, adapt and achieve economically appropriate models of comprehensive care.

Entities:  

Mesh:

Year:  2004        PMID: 15479365     DOI: 10.1111/j.1365-2516.2004.01010.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  8 in total

Review 1.  Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges.

Authors:  Federico Mingozzi; Katherine A High
Journal:  Nat Rev Genet       Date:  2011-05       Impact factor: 53.242

2.  Measuring the quality of haemophilia care across different settings: a set of performance indicators derived from demographics data.

Authors:  A Iorio; J S Stonebraker; M Brooker; J M Soucie
Journal:  Haemophilia       Date:  2016-12-08       Impact factor: 4.287

3.  Current status of Italian Registries on inherited bleeding disorders.

Authors:  Hamisa Jane Hassan; Massimo Morfini; Domenica Taruscio; Francesca Abbonizio; Adele Giampaolo; Yllka Kodra; Emily Oliovecchio; Luciano Vittozzi
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

4.  A model for a regional system of care to promote the health and well-being of people with rare chronic genetic disorders.

Authors:  Judith R Baker; Sally O Crudder; Brenda Riske; Val Bias; Ann Forsberg
Journal:  Am J Public Health       Date:  2005-09-29       Impact factor: 9.308

5.  Hemophilia care in India: a review and experience from a tertiary care centre in uttar pradesh.

Authors:  Shubha Phadke
Journal:  Indian J Hematol Blood Transfus       Date:  2011-07-12       Impact factor: 0.900

6.  Coagulation Factor IX for Hemophilia B Therapy.

Authors:  N A Orlova; S V Kovnir; I I Vorobiev; A G Gabibov
Journal:  Acta Naturae       Date:  2012-04       Impact factor: 1.845

7.  Treatment of hemophilia: a review of current advances and ongoing issues.

Authors:  Antonio Coppola; Mirko Di Capua; Matteo Nicola Dario Di Minno; Mariagiovanna Di Palo; Emiliana Marrone; Paola Ieranò; Claudia Arturo; Antonella Tufano; Anna Maria Cerbone
Journal:  J Blood Med       Date:  2010-08-30

Review 8.  The Need for Comprehensive Care for Persons with Chronic Immune Thrombocytopenic Purpura.

Authors:  Kristin T Ansteatt; Chanel J Unzicker; Marsha L Hurn; Oluwaseun O Olaiya; Diane J Nugent; Michael D Tarantino
Journal:  J Blood Med       Date:  2020-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.